Kemi Olugemo

Kemi Olugemo

Company: Akcea Therapeutics

Job title: Executive Medical Director, Neurology


Kemi Olugemo, MD, is currently Executive Medical Director and Head of Neurology at Akcea Therapeutics.

After earning her undergraduate degree in Clinical Laboratory Science from the University of Massachusetts (Magna cum Laude), Kemi completed her MD at the University of Maryland School of Medicine and remained in Baltimore for her Neurology Residency before undertaking an additional Fellowship in Neuroimmunology & Multiple Sclerosis (MS) at the Maryland Center for Multiple Sclerosis, also in Baltimore.

As a staff Neurologist and partner in the Charles County Neurology Practice, Kemi introduced a number of novel infusion therapies for the practice’s patients which in turn brought her in contact with clinical research organizations, ultimately causing her to join the industry.

Over her 12 years in clinical research, Kemi has been involved in all phases of clinical development, global medical strategy, business development, and innovations in lifecycle planning.

Prior to joining Akcea in 2019, she held increasing leadership roles at Parexel International and Questcor Pharmaceutical, Inc, and was a long-term consultant in Neurology with Quorum Independent Review Board. Kemi draws on a diverse set of experiences including being the current Director of Communications at Women of Color in Pharma (WOCIP) and serving on the Scientific Committee of the International Society for CNS Clinical Trials and Methodology (ISCTM).




Chair’s Closing Remarks & End of 2nd Biomarkers for Rare Non- Oncological Diseases Summit 2:00 pm

Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.